Perioperative Interdisciplinary, Intersectoral Process Optimization in Heart Failure - Trial NCT06381427
Access comprehensive clinical trial information for NCT06381427 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Giessen and is currently Not yet recruiting. The study focuses on Heart Failure. Target enrollment is 1057 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Giessen
Timeline & Enrollment
N/A
Sep 01, 2024
Mar 01, 2027
Primary Outcome
combined primary endpoint at 90 days post-operation : re-hospitalization,AKI, bacterial infection and cardiac decompensation
Summary
Chronic heart failure affects up to three million people in Germany, with prevalence
 increasing with age. It is a leading cause of cardiovascular disease-related deaths. Patients
 with heart failure undergoing non-cardiac surgery face higher risks of complications and
 death compared to those with coronary artery disease. Despite guidelines recommending
 comprehensive preoperative evaluation, there is no systematic risk assessment structure in
 place, leading to inadequate perioperative care. This study aims to evaluate a
 multidisciplinary approach for high-risk patients aged 65 and above, regardless of prior
 heart failure diagnosis, to mitigate postoperative complications. The investigators measure
 the NTpro BNP before surgery and include patients with NTproBNP 450 in this study and
 randomize them either to the standard care group or the intervention group.The hypothesis is
 that standardized risk screening and multidimensional care (Intervention group) can reduce
 complications in these patients undergoing non-cardiac surgery.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06381427
Non-Device Trial